We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

AstraZeneca's Nexium Patent Remains Valid

Law360 (November 19, 2007, 12:00 AM EST) -- The European Patent Office has reportedly ruled that a patent covering AstraZeneca Plc's blockbuster heartburn drug Nexium is still valid in its amended form despite challenges from four generic competitors.

AstraZeneca said Monday that its patent, which covers a proton pump inhibitor used in drugs like Nexium and Losec, will now be valid in Austria, Belgium, Switzerland, Germany, Denmark, Spain, France, the United Kingdom, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Monaco, the Netherlands, Portugal, Sweden, Latvia, Lithuania and Slovenia until 2015.

ÔÇťAstraZeneca has a comprehensive intellectual property...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.